These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 429124)

  • 1. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is matrix theory still important today?].
    Börner RH; Schneider HJ
    Z Urol Nephrol; 1982 Jun; 75(6):463-8. PubMed ID: 6812310
    [No Abstract]   [Full Text] [Related]  

  • 6. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.
    Torzewska A; Różalski A
    APMIS; 2014 Jun; 122(6):505-11. PubMed ID: 24164670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methodology for the characterization of urinary glycosaminoglycans.
    Thorne ID; Resnick MI
    J Urol; 1984 May; 131(5):995-9. PubMed ID: 6423842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary material affecting calcium oxalate monohydrate stone formation].
    Shirane Y; Yamamoto A; Mizuta K; Hiraishi K; Kurokawa K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):995-9. PubMed ID: 2607720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory factors of calcium oxalate crystal growth in urinary macromolecules].
    Matsumoto A; Terado T; Kin M; Nishio S; Iwata H; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):883-8. PubMed ID: 2402111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired observations of sulphate/uronic acid ratios in glycosaminoglycans of human dermis and urine.
    Poulsen JH; Cramers MK
    Scand J Clin Lab Invest; 1982 Apr; 42(2):107-12. PubMed ID: 6813943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.